Core Scientific, Inc.
CORZ
$14.53
$0.402.83%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -261.32% | 318.68% | 41.67% | 43.44% | -482.03% |
| Total Depreciation and Amortization | -4.12% | -23.15% | -1.97% | -5.46% | 5.69% |
| Total Amortization of Deferred Charges | -5.72% | 24.25% | 12.69% | 166.02% | -29.55% |
| Total Other Non-Cash Items | 228.02% | -219.19% | 52.79% | -54.86% | 503.48% |
| Change in Net Operating Assets | 503.41% | 105.41% | -561.28% | 313.74% | -60.64% |
| Cash from Operations | 183.75% | -394.09% | 141.64% | 374.50% | -94.57% |
| Capital Expenditure | -37.16% | -207.47% | 7.75% | -894.39% | 90.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -12,490.00% | 39.39% | -34.69% | 35.53% |
| Cash from Investing | -27.98% | -224.53% | 7.82% | -881.16% | 90.04% |
| Total Debt Issued | -- | -- | 36.31% | -- | -- |
| Total Debt Repaid | -619.89% | 67.28% | 94.84% | -1,599.46% | 9.84% |
| Issuance of Common Stock | 36.84% | -91.05% | 92.24% | 321.25% | -99.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 47.96% | -- | -100.00% |
| Cash from Financing | -656.84% | -100.70% | 228.26% | 1,299.55% | -127.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.10% | -123.71% | 272.17% | 1,012.57% | -138.53% |